Cure Today

Clinical Trial Corner: New Treatments in Leukemia, Lymphoma and Brain Cancers

SENTI-202, an off-the-shelf CAR NK cell therapy for AML, received FDA orphan drug designation, supporting its development for relapsed or refractory cases. LYL314, a CAR T-cell therapy for large ...
Medical Xpress

New study could improve testing and treatment for rare brain, spinal cord, and eye cancers

A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to ...
ascopubs.org

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia In patients with ...
ascopubs.org

Fifteen Years of Non-Hodgkin Lymphoma in an Indonesian National Referral Hospital: Epidemiologic Trends and Diagnostic Challenges

Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study The global burden of lymphoma is ...